Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.5000
0.00 (0.00%)
May 4, 2026, 4:00 PM EST
Bio Essence Revenue
In the year 2025, Bio Essence had annual revenue of $1.90M with 485.78% growth. Bio Essence had revenue of $1.48M in the quarter ending December 31, 2025, with 902.65% growth.
Revenue
1.90M
Revenue Growth
+485.78%
P/S Ratio
10.02
Revenue / Employee
948.78K
Employees
2
Market Cap
19.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.90M | 1.57M | 485.78% |
| Dec 31, 2024 | 323.94K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 621.59K | -266.39K | -30.00% |
| Dec 31, 2021 | 887.98K | -70.72K | -7.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 373.80M |
| Eagle Pharmaceuticals | 257.55M |
| MariMed | 159.83M |
| Earth Science Tech | 34.87M |
| Radnostix | 13.07M |
| CordovaCann | 10.25M |
| Healthy Extracts | 4.51M |
| Kaya Holdings | 26.69K |
Bio Essence News
- 8 days ago - Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio - Accesswire
- 2 months ago - BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026 - Accesswire